IP Library Granted Patent US 12,080,432
Granted Patent B1
US 12,080,432 · App. 15/995,966 · Granted Sep 3, 2024

Plasma metabolome as a predictor of biological aging

Inventors: Lawrence Cody Johnson (Broomfield, CO); Christopher R. Martens (Kennett Square, PA); Douglas R. Seals (Boulder, CO); Keli Parker (Ann Arbor, MI)
Assignee: The Regents of the University of Colorado
G16H50/30G01N33/5091G16B20/00G16B40/00G16H50/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,080,432
App. No.
15/995,966
Granted
Sep 3, 2024
Kind
B1
Abstract

Chronological age is an important predictor of morbidity and mortality, however it is unable to account for heterogeneity in the decline of physiological function and health with advancing age. Several attempts have been made to instead define a “biological age” using multiple physiological parameters in order to account for variation in the trajectory of human aging; however, these methods require technical expertise and are likely too time-intensive and costly to be implemented into clinical practice. Accordingly, a metabolomic signature of biological aging was developed that can predict changes in physiological function with the convenience of a blood sample. A weighted model of biological age was generated based on multiple clinical and physiological measures in a large group of healthy adults and was then applied to a cohort of healthy older adults who were tracked longitudinally over a 5-10 year timeframe. Plasma metabolomic signatures were identified that were associated with biological age, including some that could predict whether individuals would age at a faster or slower rate. These results not only have clinical implications by providing a simple blood-based assay of biological aging, but also provide insight into the molecular mechanisms underlying human healthspan.

Claims (3)

1. A method for assaying a plurality of biomarkers, wherein the method comprises:

obtaining a physiological sample from a subject; and

measuring in the physiological sample a set of biomarkers, wherein the set of biomarkers comprises (i) Oxaloacetate and Acyl-C5-OH, and (ii) 2-Phospho-D-Glycerate, Ascorbate, Selenohomocystine, 5-Acetylamino-6-formylamino-3-methyluracil, Phosphate, and Octylamine, to produce test data comprising a plurality of biomarker measures.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2018
From: JOHNSON, LAWRENCE CODY; MARTENS, CHRISTOPHER R.; SEALS, DOUGLAS R.; PARKER, KELI
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 046526/0658 →
CONFIRMATORY LICENSE Recorded Jul 5, 2018
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046271/0885 →
Continuity (1)
Provisional Application 62513758 · Jun 1, 2017